Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington. (Q50106115)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12409139%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

title

Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12409139%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12409139%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author name string

Helena J Salomé

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12409139%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Molly Carney

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12409139%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

language of work or name

English

0 references

publication date

1 December 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12409139%20AND%20SRC:MED&resulttype=core&format=json

Social Science and Medicine

14 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12409139%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12409139%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12409139%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

2267-2282

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12409139%20AND%20SRC:MED&resulttype=core&format=json

Service-level costing of drug abuse treatment.

14 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

Cost-benefit and cost-effectiveness analysis of drug abuse treatment services.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

Cost-benefit analysis of drug treatment services: review of the literature*

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

Economic evaluation of drug abuse treatment programs: methodology and findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

Health care reforms and managed care for substance abuse services: findings from eleven case studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

Estimating the dollar value of health outcomes from drug-abuse interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP).

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

Benefit-cost analysis of addiction treatment in Arkansas: specialty and standard residential programs for pregnant and parenting women

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

Estimating the economic cost of substance abuse treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

Benefit-cost analysis of residential and outpatient addiction treatment in the State of Washington.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

An analysis of short-term alcoholism treatment cost functions

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

Short term drug abuse treatment costs and utilization: a multi-employer analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

Long-term alcoholism treatment costs

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

Alcoholism treatment and total health care utilization and costs. A four-year longitudinal analysis of federal employees

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

The reduction of health care costs associated with alcoholism treatment: a 14-year longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

Alcoholism treatment and medical care costs from Project MATCH.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

Estimating health care savings associated with alcoholism treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

On valuing morbidity, cost-effectiveness analysis, and being rude

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

Benefit-cost analysis in public health

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

The Fifth Edition of the Addiction Severity Index

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

Applying benefit-cost analysis to substance use prevention programs

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

A scale of valuations of states of illness: is there a social consensus?

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

Benefit-Cost Methodology in the Evaluation of Therapeutic Services for Alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

Health Care Cost-Benefit and Cost-Effectiveness Analysis: An Overview

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2802%2900060-6

7 January 2021

10.1016/S0277-9536(02)00060-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12409139%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference